Scientists developed a starfish-shaped wearable device that leverages AI to precisely track heart health in real time with over 90% accuracy, even during movement, enabling comfortable long-term at-home monitoring with wireless charging and skin-friendly materials.
Google-backed AI drug discovery startup Isomorphic Labs secured a staggering $600 million in funding led by Thrive Capital, fueling its AI engine's development and advancing partnerships with pharmaceutical giants like Eli Lilly and Novartis worth billions to revolutionize drug design.
Alphabet's AI drug discovery subsidiary Isomorphic Labs secures $600 million funding from Thrive Capital to accelerate development of its AI-powered drug design platform and advance its drug candidates into clinical trials, leveraging technology like DeepMind's AlphaFold.
An AI algorithm trained on 80,000 cases optimizes intravenous nutrition for premature babies, reducing medical errors and costs while enhancing care efficiency and accessibility by assisting doctors in making better clinical decisions for this vulnerable population.
Amazon is pushing into generative AI with new conversational shopping and health assistants, including 'Interests AI' for product recommendations and a chatbot offering medical advice and wellness guidance.
Ant Group strategically combines Chinese and U.S. semiconductors for cost-effective AI development, enhancing its healthcare solutions by leveraging a 'mixture of experts' technique, with upgraded AI models being adopted by major Chinese hospitals.
AI technology is transforming mental health care, enhancing accessibility through 24/7 availability, aiding early diagnosis through data analysis, and supporting therapists with insights and task automation, yet human empathy and ethical oversight remain crucial.
Google unveils AI-powered health search enhancements, APIs for medical data sharing, and an FDA-cleared cardiac arrest detection feature on the Pixel Watch 3, showcasing its commitment to improving healthcare through innovative technologies.
TxAgent, an AI agent leveraging multi-step reasoning and real-time biomedical knowledge retrieval, revolutionizes personalized drug treatment with 92.1% accuracy, outperforming leading models and ensuring treatment recommendations align with clinical guidelines to reduce adverse events.
Insilico Medicine, an AI-driven drug discovery company, raised $110 million in Series E funding to propel its AI platform Pharma.AI, advance its drug pipeline, and bolster biopharmaceutical R&D, harnessing biology, clinical data, and generative chemistry for innovative drug development.